NOT-DC-20-003: Notice of NIDCD's Participation in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement

Notice of NIDCD's Participation in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)"

Notice Number: NOT-DC-20-003

Key Dates
Release Date: April 2, 2020

Related Announcements
NOT-DC-20-006 Notice of Eligibility Change for NIDCD Urgent Competitive Revisions and Administrative Supplements for Research on COVID-19.
PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)".

Issued by
National Institute on Deafness and Other Communication Disorders (NIDCD)

Purpose

The purpose of this Notice is to inform applicants that the National Institute on Deafness and Other Communication Disorders (NIDCD) will participate, effective immediately, in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)". The following changes and updates are made to PA-18-935 (shown in italics) to reflect NIDCD's participation in this funding opportunity announcement (FOA).

Part 1. Overview Information

Components of Participating Organizations

National Institute on Aging (NIA)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute on Drug Abuse (NIDA)

National Institute of Mental Health (NIMH)

National Institute of Environmental Health Sciences (NIEHS)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

National Center for Advancing Translational Sciences (NCATS)

National Institute on Deafness and Other Communication Disorders (NIDCD)

Catalog of Federal Domestic Assistance (CFDA) Number(s) 93.866; 93.855; 93.279; 93.847; 93.242, 93.113, 93.272, 93.286, 93.350, 93.173

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

For any scientific or research-related questions on this urgent competitive revisions notice please contact the Program Officer listed on the NoA of the most recent parent award.